CONSEGNA PHARMA INC
CONSEGNA PHARMA INC is a federal contractor, registered under UEI NU7SAKDR52N8 and CAGE code 806W6. It has been awarded $4,445,113 across 5 federal contracts. Primary work spans Unknown NAICS and Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Health And Human Services and Department Of Defense.
Contact Information
Registration and classification details
Registration
UEI Code
NU7SAKDR52N8CAGE Code
806W6Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Consegna Pharma Inc. specializes in scientific and technical research services within the pharmaceutical and life sciences domain, leveraging its expertise in 541715—Scientific Research and Development Services. The company delivers end-to-end research support, including preclinical study design, da...
Consegna Pharma Inc. specializes in scientific and technical research services within the pharmaceutical and life sciences domain, leveraging its expertise in 541715—Scientific Research and Development Services. The company delivers end-to-end research support, including preclinical study design, data analysis, regulatory documentation, and process optimization for drug development pipelines. Its technical capabilities encompass pharmacokinetic modeling, bioanalytical method validation, and compliance with FDA and ICH guidelines, with a focus on translating laboratory findings into actionable regulatory pathways. The firm distinguishes itself through its methodical approach to data integrity, quality assurance frameworks, and adherence to GLP and GMP standards, ensuring reproducibility and audit readiness in federally supported research initiatives. No agency relationships can be inferred from available award data, and no specific federal clients or program areas are identifiable based on current contract history. The absence of recent awards or agency-specific performance records limits the ability to characterize engagement patterns with government entities. The company’s primary NAICS classification reflects a focus on applied pharmaceutical research, positioning it within the broader life sciences R&D market. It serves as a technical partner to organizations requiring specialized scientific services for drug discovery, formulation development, and clinical trial preparation, though its market presence is not currently defined by public contract activity. Consegna Pharma Inc. is structured as a small business under the 2L entity classification and is headquartered in Pittsburgh, Pennsylvania. It holds no federal certifications such as 8(a), HUBZone, or WOSB, and its government market positioning remains undefined due to the lack of publicly available contract performance data. Its operational footprint is currently confined to its Pittsburgh base, with no indication of multi-state or national government service delivery.
Key Performance Metrics
Awards Count
All time
Active
Currently performing
Completed
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
